Tradestie Institutional Equity Comparison Engine

RACC vs MPLT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RACC Overall Edge

RACC Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to RACC (RACC) driven by superior Momentum & Technical, Options & Structure while MPLT counters with relative strength in Growth & Margin. Fundamentally, RACC trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MPLT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RACC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MPLT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RACC N/M vs MPLT N/M Fwd P/E
Growth & Margin Winner MPLT
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner RACC
1Y -2.7% vs -59.3% ยท 52W Pos 2% vs 0%
Options & Structure Winner RACC
UNCLASSIFIED (N/A IV) vs BREAKDOWN (9th %ile IV)
RACC US Equity
RACC
Institutional Equity
$10.02
+0.1% 1D
Market Cap N/A
1M Return -1.09%
1Y Return -2.72%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 39.0 Fund 38.0 Flow 50.0 Mom 38.9
MPLT US Equity
MapLight Therapeutics, Inc.
Pharmaceutical Preparations
$5.94
-7.48% 1D
Market Cap $356.8M
1M Return -28.0%
1Y Return -59.32%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 33.0 Fund 64.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RACC -2.72% MPLT -59.32% Spread: +75.92 pp (RACC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RACC TTM Op. Margin: N/A MPLT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RACC vs MPLT. Trailing 12-month operating profitability (RACC N/A vs MPLT 0.0%) and valuation multiples (RACC N/M vs MPLT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RACC (2) vs MPLT (6)
Institutional Metric RACC MPLT Criterion Row Winner
Market Capitalization Scale N/A $356.8M Larger Scale MPLT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth MPLT
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin MPLT
Net Profit Margin Profitability N/A 0.0% Higher Margin MPLT
Return on Equity (ROE) Capital Efficiency N/A -74.2% Higher ROE MPLT
52-Week Range Position Momentum 2% ($10โ€“$34) 0% ($6โ€“$40) Stronger Trend RACC
Beta / 30D Volatility Risk Regime 0.16ฮฒ ยท 6% Vol 1.19ฮฒ ยท 79% Vol Lower Realized Risk RACC
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite MPLT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RACC vs MPLT Buy Guide
RACC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RACC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MPLT BREAKDOWN
148d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live MPLT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RACC nor MPLT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.